Brief: Puma Biotechnology Inc Says Effective Dec 13, Co, Wyeth, LLC Entered Into Settlement, License Agreement With Sandoz Inc

Puma Biotechnology

16/12/2022 22:02

Dec 16 (Reuters) - Puma Biotechnology Inc  PBYI.O :
    * PUMA BIOTECHNOLOGY INC - EFFECTIVE DEC 13, CO, WYETH, LLC
ENTERED INTO SETTLEMENT, LICENSE AGREEMENT WITH SANDOZ INC
    * PUMA BIOTECHNOLOGY-DEAL SETTLES,RELEASES ALL
CLAIMS,TERMINATES
WITHOUT PREJUDICE PENDING HATCH WAXMAN PATENT INFRINGEMENT
LITIGATION
    * PUMA BIOTECHNOLOGY- POST SETTLEMENT, LICENSE AGREEMENT, CO
GRANTED SANDOZ NON-EXCLUSIVE, ROYALTY-FREE SUBLICENSE TO CERTAIN
LICENSED PATENTS
    * PUMA BIOTECHNOLOGY- SUBLICENSE WOULD PERMIT SANDOZ TO
BEGIN
SELLING GENERIC VERSION OF NERATINIB ON OR AROUND DEC 8, 2030
    * PUMA BIOTECHNOLOGY- CO, WYETH GRANTED SANDOZ WAIVER OF ANY
AND
ALL REGULATORY EXCLUSIVITIES

Further company coverage:  PBYI.O 
 ((Reuters.Briefs@thomsonreuters.com;))